Gene Query: ZMAT2

Dataset Description Geneva Score
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 45.3
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 28.07
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 27.74
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 23.68
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 21.36
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 20.82
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 18.96
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 18.62
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 18.62
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 18.57
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 17.58
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 17.58
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 17.53
Identification of transcription start sites for human A549 cell line using ReCappable-seq 15.78
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 15.09
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 14.62
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 14.32
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 13.73
Splicing and epigenetic factors jointly regulate epidermal differentiation 13.29
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 13.16
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 12.75
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.41
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.26
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 12.22
Co-transcriptional loading of RNA export factors shapes the human transcriptome 11.96
RNAseq of HEK293 cells after Chtop knockdown 11.96
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.91
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 11.85
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.79
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 11.72
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 11.48
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.88
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 10.66
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 10.47
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 10.43
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 10.43
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 10.3
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 10.27
Neurofibroma 10.16
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 10.16
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 10.14
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.11
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.1
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 9.9
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 9.9
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 9.81
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.56
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.46
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.46
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.45
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 9.41
Effect of Hotair overexpression in human breast cancer cell lines 9.39
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 9.32
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.31
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 9.26
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 9.26
T47D RNA-seq and ChrRNA-seq data 9.13
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 9.13
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 9.11
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.08
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.93
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 8.85
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 8.81
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.74
The role of FAM46C in myeloma cells 8.72
The role of FAM46C in myeloma cells [sequencing] 8.72
Widespread regulated alternative splicing of single codons accelerates proteome evolution 8.66
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 8.64
Differential gene expression of human melanoma cells [RNA-seq] 8.64
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.55
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.54
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 8.54
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.53
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 8.47
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.37
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.37
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 8.32
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 8.09
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.07
The evolution of N6-methyladenosine in primates 8.05
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.0
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.98
Transcriptomic analysis of human tonsillar TFH subsets 7.93
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 7.91
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 7.89
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.87
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.86
miRNAs affected by antagomiR-17 treatment 7.84
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 7.84
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 7.8
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.68
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.63
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.53
hTERT promotes cell adhesion and migration independent of telomerase activity 7.51
Effect of FGF13 depletion on the H460 cell line 7.4
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.39
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.39
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 7.36
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 7.36
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.34
Transcriptomic analyssis following EHMT1/2 inhibition 7.3
LncRNA-GAS5 negative regulation of YAP-target genes expression 7.29
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.23
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.22
7.2
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.18
Gene expression changes due to PARP knockdown in human cells 7.16
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 7.14
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.12
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 7.1
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.09
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 7.07
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 7.05
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 7.0
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 7.0
RNA-sequencing of healthy human skeletal myocytes 6.95
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 6.95
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 6.89
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.86
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.86
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.85
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 6.84
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 6.84
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 6.77
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.76
Mitochondrial dsRNA triggers antiviral signalling in humans 6.76
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 6.71
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.7
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 6.69
SNHG5 siRNA knock down in HCT116 cells 6.64
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 6.62
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.61
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.59
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.56
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.43
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.38
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.37
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.37
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 6.29
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.29
BAF controls genome accessibility 6.17
Characterization of parental and rociletinib-resistant derived H1975 cell lines 6.17
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.14
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.12
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.12
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.08
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 6.05
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.04
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 6.01
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 6.01
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 5.99
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.98
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.97
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 5.96
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 5.95
Hepatocyte maturation 5.88
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.87
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.86
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.83
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 5.8
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.79
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.76
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.76
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.74
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.68
Human HAP1 cells before and after nutrient deprivation 5.68
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.68
Ribosomal protein RPL26 is the principal target of UFMylation 5.66
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.65
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.64
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.63
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.63
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.61
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.6
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 5.58
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 5.57
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 5.57
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 5.56
Identification of renal resident macrophages across species 5.55
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.55
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.54
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.53
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.53
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 5.52
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.52
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.51
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 5.5
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 5.5
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.45
RNA-seq of YB5 cells treated with Proscillaridin A 5.44
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.42
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.41
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.39
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.32
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.3
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.29
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.29
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.24
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.2
UV_24h_GRO-Seq 5.18
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 5.17
ETV7 and interferon response 5.15
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.15
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.12
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.11
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.1
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.02
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.99
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.98
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.98
O-glcnAc reprograms cellular energetics 4.93
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.92
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.88
Effect of disulfiram treatment on pediatric high grade glioma 4.86
LIN28A Over-expression RNAseq 4.85
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.79
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.76
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.76
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 4.75
RNA-sequencing in immortalized human mammary epithelial cells 4.75
IMP3 regulated gene expression in breast cancer cells 4.74
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.71
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.65
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.64
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.64
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.51
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 4.51
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.49
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 4.49
Ebola virus (EBOV) infection of ARPE-19 cells 4.42
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.39
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.39
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.31
Endometrial transcriptome and PGR cistrome in cycling fertile women 4.31
Human cell line and subcutaneous tumor 4.26
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.23
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.2
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.2
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 4.19
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 4.1
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.09
scRNASeq analysis of cycling cardiomyocytes 4.06
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.0
Biological effect of chronic mistranslation in mammalian cells 3.97
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.96
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.94
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.91
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.91
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.88
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.88
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.84
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.77
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 3.75
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 3.73
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.72
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.7
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.66
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.66
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.66
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.59
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.59
SLAM-seq for K562 endogenous mRNA decay 3.59
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.57
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 3.56
Transcriptome analysis of CNS leukemia 3.55
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.55
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.53
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.52
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.5
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.43
Downregulation of DDX5/DDX17 and REST 3.43
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.38
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.38
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.37
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.37
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 3.37
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 3.35
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.35
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 3.31
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 3.31
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 3.27
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.25
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.18
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.18
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.16
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.13
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.12
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.11
Cajal bodies are linked to genome conformation 3.09
Cajal bodies are linked to genome conformation [RNA-Seq] 3.09
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.08
Measure transcript integrity using RNA-seq data 3.07
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.07
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.06
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.06
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 3.05
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.04
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.99
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.99
Illumina Total RNA-seq in HeLa 2.96
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.94
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.9
Transcriptome of diurnal human blood neutrophils 2.88
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.84
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.82
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.78
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.78
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.77
Dynamic 3D chromosomal landscapes in acute leukemia 2.77
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.74
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.73
Genome-wide analysis of Dengue virus 2 infected cells 2.72
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.71
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.7
Transcriptional effect of ETV1 knockdown in melanoma cells 2.69
Effect of PBK knockdown on C4-2 cell transcriptome 2.61
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.6
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.6
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.6
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.59
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.58
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.57
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.55
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.49
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.49
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.42
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.39
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.36
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.35
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 2.33
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.32
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.31
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.3
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.28
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.28
Total RNA-Seq data from leukemic patients with complex structural variants 2.27
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.24
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 2.23
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.22
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.21
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.2
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.2
Systematic discovery of endogenous human ribonucleoprotein complexes 2.15
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.15
Human Treg NaCl stimulation 2.13
Aging-associated patterns in the expression of human endogenous retroviruses 2.13
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.12
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.08
Expression profiling of MCF-7 cells with treatment of TCDD 2.08
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.08
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.03
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.97
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.96
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.96
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.95
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.94
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.94
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 1.93
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.89
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.87
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.86
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.85
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.84
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.83
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.77
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.77
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.76
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.73
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.73
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.62
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.6
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.58
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.54
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.54
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.53
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.51
Single-cell analysis of human kidney organoids 1.45
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.42
p63 controls the enhancer landscape during keratinocyte differentiation 1.42
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.4
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.4
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.4
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.4
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.39
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.37
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.37
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.31
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.29
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.29
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.28
Genome-wide analysis of the Integrator complex (HTS) 1.26
Genome-wide analysis of the Integrator complex 1.26
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.26
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.26
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.25
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.24
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.24
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.23
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.23
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.23
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.22
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.2
quanTIseq: quantifying immune contexture of human tumors 1.19
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.18
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.16
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.13
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.13
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.12
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.09
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.08
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.08
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.08
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.06
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.05
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.04
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.04
Gene expression profile in breast cancer cells 1.04
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.01
Global transcriptome analysis of WT versus HEB-/- hESCs 1.01
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.99
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.99
Human Treg IL-12 stimulation 0.99
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.97
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.97
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.97
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.93
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 0.93
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.93
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.93
Gene expression profiling of KSHV-infected periodontal ligament cells 0.92
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.92
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.91
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.91
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.91
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.88
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.88
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.86
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.84
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.81
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.81
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.78
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.77
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.76
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.75
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.74
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.73
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.73
Expression analysis of the TAF1 syndrome 0.68
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.66
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.64
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.63
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.61
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.61
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.61
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.6
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.58
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.56
Metabolism as an early predictor of DPSCs aging 0.56
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 0.55
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.54
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.51
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.5
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.5
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.49
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.45
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.45
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.44
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.41
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.41
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.39
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.36
The cohesin complex prevents Myc-induced replication stress 0.35
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 0.34
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.33
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.29
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.27
siRNA-mediated knockdown 0.21
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.21
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.21
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.2
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.18
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.17
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.16
Oncogenic roles of ARID5B in T-ALL 0.16
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.13
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.13
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.1
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.05
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
Transcriptome-wide modulation of splicing by the exon junction complex 0.01
Preclinical model of obesity and ER-positive breast cancer 0.01
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation